SAN ANTONIO — In the course of caring for individuals with psoriasis, clinicians should have patients complete the validated ...
When added to optimized oral anti-lipid therapy, a PCSK9 blocker provided an additional 25% risk reduction in a first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback